IDH1 and glioblastoma: For a diagnosis of “Glioblastoma, IDH-wildtype” the novel WHO CNS5 incorporates 3 genetic parameters (TERT promoter mutation, EGFR gene amplification, combined gain of entire chromosome 7 and loss of entire chromosome 10) as criteria.